RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 100.10
-4.40 (-4.21%)
Apr 29, 2026, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 73.85 billion as of April 29, 2026. Its market cap has increased by 244.97% in one year.
Market Cap
73.85B
Enterprise Value
72.80B
Revenue
3.84B
Ranking
n/a
PE Ratio
37.72
Stock Price
100.10
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 73.85B, an increase of 121.17%. That is a compound annual growth rate of 15.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 97.92B |
| 3SBio | 55.90B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.26B |
| Akeso | 126.47B |
| Biocytogen Pharmaceuticals (Beijing) | 44.62B |
| Shanghai Junshi Biosciences | 43.50B |
| Shanghai Henlius Biotech | 42.15B |
| WuXi Biologics | 139.44B |